Company: ARVN
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001655759-25-000075
Chunk: 29

Company: ARVINAS, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 29
---
” on the Investors and Media section of our website, which is located at http://www.arvinas.com. Information contained on our website is not incorporated by reference in, or considered part of, this proxy statement.

Board Leadership Structure and Board’s Role in Risk Oversight

Dr. Houston currently serves as Chairperson, Chief Executive Officer and President, and has served in this combined role since our 2023 annual meeting of stockholders. In light of this combination of roles, to continue good governance practice and in line with our corporate governance guidelines, our board of directors appointed Briggs Morrison, M.D. as lead independent director. As lead independent director, Dr. Morrison’s duties include:

• acting as chairperson in executive sessions;

• meeting with any director not adequately performing duties;

• facilitating communications between our directors and the combined Chairperson and Chief Executive Officer, as appropriate;

• monitoring stockholder communications with the assistance of our legal department;

• working with the Chairperson to prepare the agenda for meetings of our board of directors and determining whether special meetings are required; and

• otherwise consulting with the Chairperson and Chief Executive Officer on corporate governance and director performance matters.

<div align='center'>20</div>

Our board of directors continues to believe that this board leadership structure remains appropriate at this time given the following:

• Dr. Houston and Dr. Morrison have an excellent professional working relationship as demonstrated by their many years of working collaboratively; and

• Combining the roles of Chairperson and Chief Executive Officer fosters clear accountability, effective decision-making and alignment of corporate strategy, and facilitates information flow between management and our board of directors.

Our nominating and corporate governance committee and our board of directors evaluate our board leadership structure from time to time and may recommend further alterations of this structure.

Risk is inherent with every business and how well a business manages risk can ultimately determine its success. We face a number of risks, including those described under “Risk Factors” in our 2024 Annual Report. Our board of directors is actively involved in oversight of risks that could affect us. This oversight is conducted primarily by our full board of directors, which has responsibility for general oversight of risks. Our board of directors oversees our risk management processes directly and through its committees. Our management is responsible for risk management on a day-to-day basis and our board of directors and its committees oversee the risk management activities of management. Our board of directors satisfies this responsibility through full reports by each committee chair regarding the committee’s considerations and actions, as well as through regular reports directly